Key facts
- Enable Injections’s last known valuation is $930.0M (Jan 2026).
- It has raised $341.7M across 7 recorded rounds; the latest was Early Stage VC ($30.0M) in Dec 2025.
- Notable investors include Cintrifuse Capital, Magnetar Capital, CincyTech, Squarepoint Capital, Cincinnati Children's Hospital Medical Center — 14 tracked in total.
- Enable Injections has filed 16 Form Ds with the SEC since 2014, most recently Feb 2022 ($150.0M sold to 22 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 7 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Enable Injections
Funding rounds
7 roundsAbout Enable Injections
Operator of a healthcare innovation company intended to improve the patient treatment experience through the development of wearable drug delivery products. The company's devices are high-volume injectors that utilize any standard container closure system, including a syringe, vial, or cartridge, enabling patients to easily, comfortably, and control self-administration.
- Sector
- Healthcare
- HQ
- Cincinnati, OH, United States
- Founded
- 2010
- Employees
- 193
- Website
- enableinjections.com/
- Ownership
- Privately Held (backing)
Enable Injections doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enable Injections shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enable Injections in its N-PORT filings yet. We sweep new filings monthly.